Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS), sold 21,414 shares at $9.09 ($195K) on 2025-01-13, disclosed to the SEC on 2025-01-15.
Scheduled sale ($195k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.09 | 10,657 | $97K | 49.8% |
| 2 | $9.09 | 10,657 | $97K | 49.8% |
| 3 | $9.63 | 100 | $963 | 0.5% |
| Total | $9.09 avg | 21,414 | $195K | 100% |
| Filing → |
| MLYS | SELL | 2025-10-15 | $904K | — | Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |